Concepedia

J. J. Kavanagh

JJ

31

Publications

1.3K

Citations

17

H-Index

1986

Active since

Affiliations

The University of Texas MD Anderson Cancer Center(Current)

Samsung Medical Center

J. J. Kavanagh is an author at The University of Texas MD Anderson Cancer Center specializing in oncology, medicine, and obstetrics.

Top concepts

Publications per year

1986–2012

31

Publications

31

Frequent loss of heterozygosity on chromosomes 6q, 11, and 17 in human ovarian carcinomas.

J H Lee, J. J. Kavanagh, David M. Wildrick et al. · PubMed · 1990 · 192 citations

, , +23

Carboplatin reinduction after taxane in patients with platinum-refractory epithelial ovarian cancer.

J. J. Kavanagh, Damrong Tresukosol, Creighton L. Edwards et al. · Journal of Clinical Oncology · 1995 · 125 citations

Increased expression of fascin, motility associated protein, in cell cultures derived from ovarian cancer and in borderline and carcinomatous ovarian tumors

Wei Hu, Pierre D. McCrea, Michael T. Deavers et al. · Clinical & Experimental Metastasis · 2000 · 110 citations

Phase 3 randomised study of canfosfamide (Telcyta®, TLK286) versus pegylated liposomal doxorubicin or topotecan as third-line therapy in patients with platinum-refractory or -resistant ovarian cancer

Ignace Vergote, N. Finkler, J. Del Campo et al. · European Journal of Cancer · 2009 · 102 citations

, , +9

Retinoic acid and interferon in human cancer: mechanistic and clinical studies.

D M Moore, D V Kalvakolanu, S. M. Lippman et al. · PubMed · 1994 · 87 citations

Rows per page

1–5 of 31